US Stock MarketDetailed Quotes

CDT Conduit Pharmaceuticals

Watchlist
  • 0.082
  • -0.001-0.61%
Close Dec 13 16:00 ET
  • 0.078
  • -0.004-4.29%
Post 20:02 ET
9.52MMarket Cap-0.39P/E (TTM)

About Conduit Pharmaceuticals Company

Conduit Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of clinical assets to address the unmet medical needs of patients, through exclusive relationships in the areas of autoimmune disease and idiopathic male infertility. The company is headquartered in Naples, FL.

Company Profile

SymbolCDT
Company NameConduit Pharmaceuticals
Listing DateMar 28, 2022
CEOMr. David Tapolczay
MarketNASDAQ
Employees7
Fiscal Year Ends12-31
Address4581 Tamiami Trail North,Suite 200
CityNaples
ProvinceFlorida
CountryUnited States of America
Zip Code34103
Phone1-646-491-9132
Websitehttp://www.conduitpharma.com

Company Executives

  • Name
  • Position
  • Salary
  • David Tapolczay
  • Chief Executive Officer and Director
  • 1.34M
  • James Bligh
  • Director, Senior Vice President, Strategy and Interim Chief Financial Officer
  • --
  • Dr. Freda C. Lewis-Hall,M.D.
  • Chairman of the Board
  • 275.31K
  • Simon Fry
  • Director
  • --
  • Dr. Andrew James Regan
  • Director
  • 842.08K
  • Faith L. Charles
  • Independent Director
  • 267.43K
  • Chele Chiavacci Farley
  • Independent Director
  • 268.93K
Heat List
US
Overall
Symbol
Price
% Chg

No Data